Observational studyBMC infectious diseases2026
Towards precision dosing of contezolid: moderate hepatic impairment increases plasma concentration of contezolid in anti-tuberculosis treatment.
Hong Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.